International Journal of Immunotherapy and Cancer Research Submit Manuscript

    About IJICR

    International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health care by bringing researchers and practitioners together from academia and industry to focus on advanced research in immune system and cancer. Journal multidisciplinary approach draws together information and research in a diverse range of oncology. Journal provides a platform for Scientists, Physicists, Chemists, Biologists, Environmentalist and Physicians to communicate rapidly.

    The journal is characterized by the rapid reporting of reviews, original research, news and views, articles, clinical reports, mini reviews, short communications, and letters to the editor and application studies across all the fields of Oncology. Authors are solicited to contribute to this journal by submitting articles that illustrate research results, projects, case reports, surveying works and industrial experiences that describe significant advances in immunology and cancer.

    International Journal of Immunotherapy and Cancer Research is an international journal in all areas of immunotherapy, including cellular immunology, non cellular immunotherapy (monoclonal antibodies), gene therapy, clinical immunology, hematology, oncology, allergology, rheumatology, and molecular biology, carcinogenesis, cancer cell biology, cancer genetics, infectious causes of cancer, tumor immunology, early detection and diagnosis, epidemiology, and cancer therapy with special interest in cellular immunotherapy. The journal aims to provide the most complete and reliable source of information on current developments in the field. The emphasis will be on publishing quality articles rapidly and making them freely available to researchers worldwide.

    Scope of the journal covers: Cell and tumor biology, endocrinology, epidemiology, experimental therapeutics, molecular targets and chemical biology, immunology, molecular biology, patho-biology and genetics, prevention, pharmacology and physiology tumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune response, oncolytic viruses, cancer genetics, cancer cytology, cancer pathology, gynecologic cancer, ovarian cancer, clinical aspects of breast cancer, Lung cancer, cancer endocrinology , genitourinary cancer, colorectal cancer, bone cancer, prostate cancer, etc.

    • Allergy, Autoimmunity, Biotechnology
    • Clinical Laboratory Immunology, Gene Therapy
    • HIV, Immunodermatology, Immunohematology
    • Immunologic deficiency states and their reconstitution
    • Immunologic surveillance and tumor immunity
    • Immunomodulation, Immunotherapy, Lymphokines and cytokines